NCT03253328View on ClinicalTrials.gov

N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

August 31, 2021

Study Completion Date

June 27, 2022

Conditions
Diabetes MellitusCritical Limb IschemiaLower Limb Amputation KneePeripheral Arterial Disease
Interventions
DRUG

Active Arm N-acetyl cysteine (NAC)

N-acetyl cysteine (NAC) 1200mg twice a day for 6 days post-amputation

DRUG

Placebo Arm

Placebo 1/2 normal saline infusion twice a day for 6 days post-amputation

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03253328 - N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes | Biotech Hunter | Biotech Hunter